Hualan Biological Engineering Inc. (SHE:002007)

China flag China · Delayed Price · Currency is CNY
14.47
+0.01 (0.07%)
Apr 28, 2026, 3:04 PM CST
-11.01%
Market Cap 26.44B
Revenue (ttm) 4.49B
Net Income (ttm) 857.61M
Shares Out 1.83B
EPS (ttm) 0.47
PE Ratio 30.81
Forward PE 22.85
Dividend 1.00 (6.92%)
Ex-Dividend Date Oct 27, 2025
Volume 7,942,528
Average Volume 8,901,568
Open 14.73
Previous Close 14.46
Day's Range 14.40 - 14.73
52-Week Range 14.14 - 18.39
Beta 0.45
RSI 37.75
Earnings Date Apr 27, 2026

About SHE:002007

Hualan Biological Engineering Inc., together with its subsidiaries, engages in the research, development, production, and sale of biological products in China and internationally. The company offers blood products, including human serum albumin, human prothrombin complex concentrate, human coagulation factor VIII, human fibrinogen, and freeze-dried human fibrin glue for surgical use, as well as intravenous, human, rabies, hepatitis B, and tetanus immunoglobulin for various therapeutic applications. It also provides vaccine products, such as inf... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1992
Employees 4,117
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002007
Full Company Profile

Financial Performance

In 2025, SHE:002007's revenue was 4.60 billion, an increase of 4.93% compared to the previous year's 4.38 billion. Earnings were 940.40 million, a decrease of -13.55%.

Financial Statements

News

There is no news available yet.